A comprehensive examination by two pathologists reported that a similar percentage of Gpx4+/− and control mice (55–60%) had neoplastic disease, although an age-related delay in fatal lymphoma was seen in Gpx4+/− mice [74]. This evidence concerns the gene GPX4 and lymphoma.